Encodia

About:

Encodia is a biotech company that develops the next generation of protein analysis tools.

Twitter/X: encodiabio

Top Investors: Deerfield, Google Ventures, Alexandria Venture Investments, ARCH Venture Partners, Tao Capital Partners

Description:

Encodia provides in-depth information on cellular processes to enable personalized medicine. Our technology reverse translates peptide sequence information into a DNA library. This means scientists can scale their research more easily to accelerate novel approaches to our most challenging diseases. Encodia was established on January 1, 2015 in San Diego, California.

Total Funding Amount:

$75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2015-01-01

Founders:

Julie Sunderland, Kevin Gunderson, Mark Chee, Michael Weiner

Number of Employees:

51-100

Last Funding Date:

2021-01-27

IPO Status:

Private

Industries: